Commercial AI Matches Cytopathologists in EUS Tissue Adequacy Study
Prospective Gut study found commercial AI matched onsite cytopathologists for EUS tissue adequacy and neoplastic lesions, but not benign disease.
Digestive disease, hepatology, endoscopy and inflammatory bowel disease.
Digestive disease, hepatology, endoscopy and inflammatory bowel disease.